US Stock MarketDetailed Quotes

GPCR Structure Therapeutics

Watchlist

52.740
+18.540+54.21%

Close Jun 3 16:00 ET

55.900
+3.160+5.99%

Post 18:40 ET

2.46BMarket Cap-25174P/E (TTM)

Structure Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

62.93%32.02M

95.53%102.78M

139.23%30.99M

105.98%26.15M

86.15%25.99M

51.71%19.65M

39.43%52.56M

-2.40%12.96M

12.69M

13.96M

Selling and administrative expenses

74.03%11.34M

99.61%32.67M

138.29%10.95M

144.27%8.63M

74.01%6.58M

46.05%6.51M

90.66%16.37M

36.50%4.6M

--3.53M

--3.78M

-General and administrative expense

74.03%11.34M

99.61%32.67M

138.29%10.95M

144.27%8.63M

74.01%6.58M

46.05%6.51M

90.66%16.37M

36.50%4.6M

--3.53M

--3.78M

Research and development costs

57.43%20.68M

93.69%70.1M

139.74%20.04M

91.21%17.52M

90.66%19.41M

54.67%13.14M

24.33%36.19M

-15.62%8.36M

--9.16M

--10.18M

Operating profit

-62.93%-32.02M

-95.53%-102.78M

-139.23%-30.99M

-105.98%-26.15M

-86.15%-25.99M

-51.71%-19.65M

-39.43%-52.56M

2.40%-12.96M

-12.69M

-13.96M

Net non-operating interest income expense

253.62%6.01M

965.31%13.39M

585.79%6.18M

670.20%2.69M

3,617.11%2.83M

2,562.32%1.7M

1,130.33%1.26M

90,200.00%901K

349K

76K

Total other finance cost

-253.62%-6.01M

-965.31%-13.39M

-585.79%-6.18M

-670.20%-2.69M

-3,617.11%-2.83M

-2,562.32%-1.7M

-1,130.33%-1.26M

-90,200.00%-901K

---349K

---76K

Other net income (expense)

Income before tax

-44.89%-26.01M

-74.22%-89.38M

-105.85%-24.82M

-90.03%-23.46M

-66.83%-23.16M

-37.85%-17.95M

-35.66%-51.3M

9.19%-12.06M

-12.34M

-13.88M

Income tax

16.00%29K

1,288.24%236K

-73.33%-312K

454.79%405K

84.38%118K

-58.33%25K

-92.64%17K

-322.22%-180K

73K

64K

Net income

-44.85%-26.04M

-74.63%-89.62M

-106.34%-24.5M

-92.17%-23.86M

-66.91%-23.28M

-37.41%-17.98M

-34.88%-51.32M

-22.25%-11.88M

-12.42M

-13.95M

Net income continuous Operations

-44.85%-26.04M

-74.63%-89.62M

-106.34%-24.5M

-92.17%-23.86M

-66.91%-23.28M

-37.41%-17.98M

-34.88%-51.32M

11.09%-11.88M

---12.42M

---13.95M

Minority interest income

Net income attributable to the parent company

-44.85%-26.04M

-74.63%-89.62M

-106.34%-24.5M

-92.17%-23.86M

-66.91%-23.28M

-37.41%-17.98M

-28.28%-51.32M

-1.73%-11.88M

-12.42M

-13.95M

Preferred stock dividends

Other preferred stock dividends

-59.68%1.52M

1.52M

Net income attributable to common stockholders

-44.85%-26.04M

-69.62%-89.62M

-106.34%-24.5M

-92.17%-23.86M

-50.55%-23.28M

-37.41%-17.98M

-20.73%-52.84M

23.04%-11.88M

-12.42M

-15.46M

Basic earnings per share

24.00%-0.57

-75.89%-2.43

-54.58%-0.48

-29.29%-0.63

1.12%-0.6

-46.10%-0.75

19.56%-1.3816

48.72%-0.3105

-0.4873

-0.6068

Diluted earnings per share

24.00%-0.57

-75.89%-2.43

-54.58%-0.48

-29.29%-0.63

1.12%-0.6

-46.10%-0.75

19.56%-1.3816

48.72%-0.3105

-0.4873

-0.6068

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	62.93%32.02M	95.53%102.78M	139.23%30.99M	105.98%26.15M	86.15%25.99M	51.71%19.65M	39.43%52.56M	-2.40%12.96M	12.69M	13.96M
Selling and administrative expenses	74.03%11.34M	99.61%32.67M	138.29%10.95M	144.27%8.63M	74.01%6.58M	46.05%6.51M	90.66%16.37M	36.50%4.6M	--3.53M	--3.78M
-General and administrative expense	74.03%11.34M	99.61%32.67M	138.29%10.95M	144.27%8.63M	74.01%6.58M	46.05%6.51M	90.66%16.37M	36.50%4.6M	--3.53M	--3.78M
Research and development costs	57.43%20.68M	93.69%70.1M	139.74%20.04M	91.21%17.52M	90.66%19.41M	54.67%13.14M	24.33%36.19M	-15.62%8.36M	--9.16M	--10.18M
Operating profit	-62.93%-32.02M	-95.53%-102.78M	-139.23%-30.99M	-105.98%-26.15M	-86.15%-25.99M	-51.71%-19.65M	-39.43%-52.56M	2.40%-12.96M	-12.69M	-13.96M
Net non-operating interest income expense	253.62%6.01M	965.31%13.39M	585.79%6.18M	670.20%2.69M	3,617.11%2.83M	2,562.32%1.7M	1,130.33%1.26M	90,200.00%901K	349K	76K
Total other finance cost	-253.62%-6.01M	-965.31%-13.39M	-585.79%-6.18M	-670.20%-2.69M	-3,617.11%-2.83M	-2,562.32%-1.7M	-1,130.33%-1.26M	-90,200.00%-901K	---349K	---76K
Other net income (expense)
Income before tax	-44.89%-26.01M	-74.22%-89.38M	-105.85%-24.82M	-90.03%-23.46M	-66.83%-23.16M	-37.85%-17.95M	-35.66%-51.3M	9.19%-12.06M	-12.34M	-13.88M
Income tax	16.00%29K	1,288.24%236K	-73.33%-312K	454.79%405K	84.38%118K	-58.33%25K	-92.64%17K	-322.22%-180K	73K	64K
Net income	-44.85%-26.04M	-74.63%-89.62M	-106.34%-24.5M	-92.17%-23.86M	-66.91%-23.28M	-37.41%-17.98M	-34.88%-51.32M	-22.25%-11.88M	-12.42M	-13.95M
Net income continuous Operations	-44.85%-26.04M	-74.63%-89.62M	-106.34%-24.5M	-92.17%-23.86M	-66.91%-23.28M	-37.41%-17.98M	-34.88%-51.32M	11.09%-11.88M	---12.42M	---13.95M
Minority interest income
Net income attributable to the parent company	-44.85%-26.04M	-74.63%-89.62M	-106.34%-24.5M	-92.17%-23.86M	-66.91%-23.28M	-37.41%-17.98M	-28.28%-51.32M	-1.73%-11.88M	-12.42M	-13.95M
Preferred stock dividends
Other preferred stock dividends		0	0	0	0		-59.68%1.52M	0	0	1.52M
Net income attributable to common stockholders	-44.85%-26.04M	-69.62%-89.62M	-106.34%-24.5M	-92.17%-23.86M	-50.55%-23.28M	-37.41%-17.98M	-20.73%-52.84M	23.04%-11.88M	-12.42M	-15.46M
Basic earnings per share	24.00%-0.57	-75.89%-2.43	-54.58%-0.48	-29.29%-0.63	1.12%-0.6	-46.10%-0.75	19.56%-1.3816	48.72%-0.3105	-0.4873	-0.6068
Diluted earnings per share	24.00%-0.57	-75.89%-2.43	-54.58%-0.48	-29.29%-0.63	1.12%-0.6	-46.10%-0.75	19.56%-1.3816	48.72%-0.3105	-0.4873	-0.6068
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall